Trial NCT04177602

View at ClinicalTrials.gov 
Org. Study IDs: TARC-01

Last trial update was posted on 2023-02-22

MeSH Interventions

Capecitabine Trifluridine

MeSH Conditions

Rectal Neoplasms

Other Conditions

Locally Advanced Rectal Cancer

Stopping Reasons

Due to the amended therapy strategies for rectal cancer recently, it was decided not to transfer the study to the phase II part, as superiority over standard chemoradiation and transfer to a new therapy standard are increasingly unlikely.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID